In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Teva Wins ratiopharm, As it Moves to Solidify its EU Position

Executive Summary

The purchase of the privately held ratiopharm Group solidifies Teva's number one position in the European generics industry and fits well with its goal of expanding the gap between itself and competitors. Importantly, it gives Teva a firm standing in Germany, where it had been a minor player.
Advertisement

Related Content

More Deal Of The Year Nominees
Deals Of The Week: Sanofi, Teva, Ablexis; Kadmon Emerges From Stealth Mode
Biopharma Quarterly Statistics Q1 2010
Biopharma Quarterly Statistics Q1 2010
Teva's Growth Strategy In Europe: Bullish on Germany (Part 1 of 2)
Watson Acquires Arrow Group And Expands Its Global Footprint

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV003484

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel